跳至主要内容
临床试验/NCT02946450
NCT02946450Unknown不适用

Multi-center, Prospective, Non-interventional, Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

Daewoong Pharmaceutical Co. LTD.1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2014年3月最近更新:
适应症
相关药物

试验速览

阶段
不适用
发起方
入组人数
3,000
试验地点
1
主要终点
adverse events, adverse drug reaction, serious adverse events, serious drug reaction, laboratory data, vital signs

研究概览

简要总结

The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • subjects in need of CT scanning
  • subjects who signed up informed consent

排除标准

  • Known allergy or hypersensitivity to the study medication, ingredient of the medication, and Iodine type medication
  • severe renal insufficiency patients
  • severe hypothyroidism
  • severe local infection or bacteremia

结局指标

主要结局

adverse events, adverse drug reaction, serious adverse events, serious drug reaction, laboratory data, vital signs

时间窗: 14 days

次要结局

未报告次要终点

研究者

发起方
Daewoong Pharmaceutical Co. LTD.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Observational Study to Assess the Safety of... | 临床试验